ViVitro Labs at EuroPCR 2023
The EuroPCR trade show attracts over 10 000 medical professionals for four days of scientific discoveries in cardiovascular medicine at Palais Des Congress de Paris from 16th to 19th May 2023.
Connect with Jérémie Decressac, Business Development Manager, Europe, Africa, Israel, ViVitro Labs at EuroPCR 2023 to discuss your cardiovascular device testing and engineering challenges.
ViVitro Labs Heart Valve Durability Tester with ADC™ technology
ViVitro Labs Heart Valve Durability Tester with ADC™ technology offers greater accuracy, less manual interaction saves time
ADC automates individual test module stroke and pressure control.
- Dedicated linear electromagnetic motor utilizes position feedback for consistent
heart valve opening.
- By-pass restrictor with patented control algorithm automatically maintains valve
- Continuous real-time data analysis counts every ISO cycle and yields 0% count error.
A prewired controller unit and data acquisition system accommodates any combination of up to 6 test modules.
Transparent customizable test chambers are designed for maximum flexibility to fit any valve size and geometry with optimum inflow, outflow, and lateral visibility on test samples.
ViVitro’s Heart Valve Durability Tester with ADC Technology has independent test modules that enable fast, easy interchangeability of test samples and system components with minimum disruptions to adjacent on-going test modules.
Automatic Dual Control technology maintains valve loading conditions throughout the entire test for up to 6 individually controlled chambers.
Flow Loop System autonomously runs under a low hydrostatic pressure head, which decreases the load on all seals and bellows. No external pressure source or compressor is required.
Contact us to learn more about the Heart Valve Durability Tester with ADC Technology and how ViVitro can help you meet your cardiovascular device testing needs.
ViVitro Pulse Duplicator system
The ViVitro Pulse Duplicator system is the world’s most widely cited and most used in-vitro cardiovascular hydrodynamic testing system.
The ViVitro Pulse Duplicator simulates the function of the heart (left or right) by generating pulsatile flow through prosthetic heart valves placed in the Model Heart (Left or Right). Powered by the ViVitro SuperPump pulsatile pump, it is composed of the ViVitro Model Heart (Left or Right), SuperPump pulsatile pump, Flow Measuring System and ViViTest data acquisition system. The components work together to assess the performance of prosthetic heart valves under simulated cardiac conditions. The ViVitro Pulse Duplicator System is used by the US Food and Drug Administration and is recognised and used by regulatory bodies worldwide including TÜV, BSI and Chinese CFDA.
The Pulse Duplicator System assesses the performance of cardiovascular devices and prosthetic heart valves under simulated cardiac conditions. It simulates physiological or other complex flow variations while allowing the user to vary the peripheral resistance and compliance of the system. Pressure ports and flow measuring locations allow for data to be collected from aortic or mitral sites. Transparent viewpoints allow multiple viewing angles of the valve including inflow and outflow.
Combined with the ViVitest software control system, it quickly, easily and reliably collects and analyzes physiological flow and pressure data. The ViVitest software also allows the user to easily modify and customize waveforms.
View ViVitro Pulse Duplicator web page.
The ViVitro Pulse Duplicator System is cited in numerous research studies throughout the world. Visit our Citation Database for the current list of applications and articles.
Cardiovascular Device Testing Services
ViVitro Labs offers cardiovascular device testing services as either ISO 17025:2017 accredited or non accredited to help device manufacturers meet the highest standards in the industry in support of regulatory submissions.
Connect with Jérémie Decressac, ViVitro Labs Business Development Manager, Europe, Africa, Israel, at EuroPCR 2023 to discuss your cardiovascular device testing and engineering challenges.